Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Cerilliant
Citi
McKinsey
Farmers Insurance
Argus Health
Federal Trade Commission
Fish and Richardson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050823

« Back to Dashboard

NDA 050823 describes CEFTAZIDIME IN DEXTROSE CONTAINER, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the CEFTAZIDIME IN DEXTROSE CONTAINER profile page.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 050823
Tradename:CEFTAZIDIME IN DEXTROSE CONTAINER
Applicant:B Braun
Ingredient:ceftazidime
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050823
Ingredient-typeCephalosporins
Medical Subject Heading (MeSH) Categories for 050823
Suppliers and Packaging for NDA: 050823
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823 NDA B. Braun Medical Inc. 0264-3143 N 0264-3143-11
CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823 NDA B. Braun Medical Inc. 0264-3145 N 0264-3145-11

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE
Approval Date:Jun 13, 2011TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE
Approval Date:Jun 13, 2011TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
UBS
US Army
Merck
Colorcon
McKinsey
Teva
Daiichi Sankyo
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.